, The New York Times; U.S. Accuses Harvard Scientist of Concealing Chinese Funding
“Charles M. Lieber, the chair of Harvard’s
department of chemistry and chemical biology, was charged on Tuesday with
making false statements about money he had received from a Chinese
government-run program, part of a broad-ranging F.B.I. effort to
root out theft of biomedical research from American laboratories.
Dr. Lieber, a leader in the field of nanoscale electronics, was one of three
Boston-area scientists accused on Tuesday of working on behalf of China. His
case involves work with the Thousand Talents Program, a state-run program that
seeks to draw talent educated in other countries.
American officials are investigating hundreds of cases of suspected theft of
intellectual property by visiting scientists, nearly all of them Chinese
nationals or of Chinese descent. Some are accused of obtaining patents in China
based on work that is funded by the United States government, and others of
setting up laboratories in China that secretly duplicated American research.”
Issues and developments related to IP, AI, and OM, examined in the IP and tech ethics graduate courses I teach at the University of Pittsburgh School of Computing and Information. My Bloomsbury book "Ethics, Information, and Technology", coming in Summer 2025, includes major chapters on IP, AI, OM, and other emerging technologies (IoT, drones, robots, autonomous vehicles, VR/AR). Kip Currier, PhD, JD
Showing posts with label theft of biomedical research from US labs. Show all posts
Showing posts with label theft of biomedical research from US labs. Show all posts
Tuesday, January 28, 2020
Subscribe to:
Posts (Atom)